Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia

Summary

This study will evaluate whether talnetant (200mg, 400mg, 600mg) twice a day is effective compared to placebo and risperidone 1-3mg twice a day in treating the positive and negative symptoms of schizophrenia. Study subjects will be treated with study drug for up to 6 weeks and will then return for a follow-up visit 2 weeks later. About 275 patients with schizophrenia will be enrolled in this study.

Timeline

Start

2004-12

Primary completion

2005-10

Completion

2005-10

Drugs

Indications